In conclusion, the activation of TLR 2 and/or 4 upregulated the expression of Lox-1 through activation of MAPK in BMCs but not in osteoblasts, suggesting the promotion of osteoclastogenesis during dyslipidemia. This evidence concerns the gene OLR1 and metabolic syndrome.